SCHEMBL32687995

SCHEMBL32687995

COC(=O)c1cccc(-c2cc(=O)[nH]c(S)c2C#N)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.45
▸ RECQL P46063 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ ASH1L Q9NR48 1/20 0.44
▸ AXL P30530 1/20 0.42
▸ PLAU P00749 1/20 0.41
▸ CA12 O43570 1/20 0.41
▸ CA1 P00915 1/20 0.41
▸ CA2 P00918 1/20 0.41
▸ CA9 Q16790 1/20 0.41
▸ CDK8 P49336 1/20 0.40
▸ NEK1 Q96PY6 2/20 0.40
▸ ERN1 O75460 1/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ MAPT P10636 1/20 0.40
▸ BLM P54132 1/20 0.40
▸ SAE1 Q9UBE0 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688304 0.88 KDM4E (0.47) KMT2AKDM4ERECQLTDP1ALDH1A1
SCHEMBL32688045 0.87 ACMSD (0.46) POLBKDM4ERECQLTDP1ALDH1A1
SCHEMBL32688042 0.85 ACMSD (0.52) KDM4ERECQLTDP1
SCHEMBL32688402 0.82 POLB (0.49) POLBKMT2AMEN1PLAUCA12
SCHEMBL32688076 0.77 KDM4E (0.50) KMT2AMEN1KDM4ERECQLTDP1
SCHEMBL19849665 0.76 CA12 (0.45) POLBKMT2AMEN1ASH1LAXL
SCHEMBL7823524 0.76 RAB9A (0.48) POLBKMT2AMEN1ASH1LAXL
SCHEMBL32688306 0.76 KMT2A (0.59) POLBKMT2AMEN1RECQLALDH1A1
SCHEMBL11937452 0.74 AXL (0.49) ASH1LAXLPLAUCA12CA1
SCHEMBL20339582 0.73 KMT2A (0.64) POLBKMT2AMEN1RECQLALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK POLB 508/4885KMT2A 3400/4885MEN1 4353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback